🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II

Recruitingn/aAges 18 Years - anyAllCentral Hospital, Nancy, France
NCT04394052 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients suspected to have a bone or soft-tissue tumor referred for imaging for initial tumors characterization and staging. Exclusion Criteria: * Pregnancy * Breast feeding patients * Renal insufficiency * Contra indications to MRI or CT * Prior surgery or treatment to the evaluated lesion.
💊

What it tests

  • MR imaging
📍

Where

1 site
CHU-Nancy
Nancy, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy